Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette N Lamb

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Drugs|May 13, 2021
Correction to: Inclisiran: First ApprovalYvette N Lamb
Drugs|January 18, 2022
Somatrogon: First ApprovalYvette N Lamb
Drugs|February 22, 2022
Ocrelizumab: A Review in Multiple SclerosisYvette N Lamb
Drugs|September 21, 2018
Elotuzumab: A Review in Relapsed and/or Refractory Multiple MyelomaYvette N Lamb
Drugs|September 9, 2018
Elagolix: First Global ApprovalYvette N Lamb
Drugs|November 22, 2019
Lasmiditan: First ApprovalYvette N Lamb
Paediatric Drugs|October 20, 2023
Correction to: Viloxazine: Pediatric First ApprovalYvette N Lamb
Drugs|May 29, 2021
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|December 17, 2020
Correction to: Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple MyelomaYvette N Lamb
Drugs|November 1, 2018
Galcanezumab: First Global ApprovalYvette N Lamb
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Drugs|May 13, 2021
Correction to: Inclisiran: First ApprovalYvette N Lamb
Drugs|January 18, 2022
Somatrogon: First ApprovalYvette N Lamb
Drugs|February 22, 2022
Ocrelizumab: A Review in Multiple SclerosisYvette N Lamb
Drugs|September 21, 2018
Elotuzumab: A Review in Relapsed and/or Refractory Multiple MyelomaYvette N Lamb
Drugs|September 9, 2018
Elagolix: First Global ApprovalYvette N Lamb
Drugs|November 22, 2019
Lasmiditan: First ApprovalYvette N Lamb
Paediatric Drugs|October 20, 2023
Correction to: Viloxazine: Pediatric First ApprovalYvette N Lamb
Drugs|May 29, 2021
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|December 17, 2020
Correction to: Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple MyelomaYvette N Lamb
Drugs|November 1, 2018
Galcanezumab: First Global ApprovalYvette N Lamb
Pageof 8